231 related articles for article (PubMed ID: 25472996)
1. The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation.
Zimmermann K; Liechti T; Haas A; Rehr M; Trkola A; Günthard HF; Oxenius A
J Immunol; 2015 Jan; 194(2):637-49. PubMed ID: 25472996
[TBL] [Abstract][Full Text] [Related]
2. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
[TBL] [Abstract][Full Text] [Related]
3. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
Hubert P; Bismuth G; Körner M; Debré P
Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
[TBL] [Abstract][Full Text] [Related]
6. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation.
Cefai D; Ferrer M; Serpente N; Idziorek T; Dautry-Varsat A; Debre P; Bismuth G
J Immunol; 1992 Jul; 149(1):285-94. PubMed ID: 1535086
[TBL] [Abstract][Full Text] [Related]
7. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
[TBL] [Abstract][Full Text] [Related]
8. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation.
Tuen M; Visciano ML; Chien PC; Cohen S; Chen PD; Robinson J; He Y; Pinter A; Gorny MK; Hioe CE
Eur J Immunol; 2005 Sep; 35(9):2541-51. PubMed ID: 16106369
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
[TBL] [Abstract][Full Text] [Related]
10. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
11. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein.
Schwartz O; Alizon M; Heard JM; Danos O
Virology; 1994 Jan; 198(1):360-5. PubMed ID: 7903129
[TBL] [Abstract][Full Text] [Related]
12. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
Westendorp MO; Frank R; Ochsenbauer C; Stricker K; Dhein J; Walczak H; Debatin KM; Krammer PH
Nature; 1995 Jun; 375(6531):497-500. PubMed ID: 7539892
[TBL] [Abstract][Full Text] [Related]
14. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
Kanner SB; Haffar OK
J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
[TBL] [Abstract][Full Text] [Related]
16. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
17. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
Wang ZQ; Orlikowsky T; Dudhane A; Mittler R; Blum M; Lacy E; Riethmüller G; Hoffmann MK
Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
[TBL] [Abstract][Full Text] [Related]
18. Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression.
Oberg HH; Sanzenbacher R; Lengl-Janssen B; Dobmeyer T; Flindt S; Janssen O; Kabelitz D
J Immunol; 1997 Dec; 159(11):5742-9. PubMed ID: 9548519
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
[TBL] [Abstract][Full Text] [Related]
20. High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression.
Chien PC; Cohen S; Kleeberger C; Giorgi J; Phair J; Zolla-Pazner S; Hioe CE
J Infect Dis; 2002 Jul; 186(2):205-13. PubMed ID: 12134256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
